<DOC>
	<DOCNO>NCT01097681</DOCNO>
	<brief_summary>The primary objective study compare pharmacokinetics ASP1941 type 2 diabetes mellitus patient normal renal function mild moderate renal impairment .</brief_summary>
	<brief_title>A Study Assess Pharmacokinetics , Pharmacodynamics ASP1941 Diabetes Mellitus Patients With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Type 2 diabetic patient least 12 week Fasting plasma glucose level &lt; 240 mg/dL Body Mass Index ( BMI ) 20.0 35.0kg/m2 GFR value base Japanese GFR estimation equation screening , â‰¥ 30 ml/min/1.73m2 Type 1 diabetes mellitus patient Receiving insulin within 12 week screen Diabetic ketoacidosis Dysuria and/or urinary tract infection , genital infection Significant renal , hepatic cardiovascular disease Severe gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Urinary glucose excretion</keyword>
</DOC>